RANDY STIGLIANO: Open Payments
NPI 1396741278 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 14 payments from 7 companies in 2025. Trend: 2023 $195 · 2024 $247 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $139 |
| Indivior Inc. | 3 | $75 |
| Novo Nordisk Inc | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $23 |
Products named: REPATHA, SUBLOCADE, XIFAXAN, Ozempic, MOUNJARO, REXULTI, Cologuard Collection Kit, Wegovy.
Industry payments across FL — which companies pay providers there.
